Brokerages Anticipate CME Group Inc. (NASDAQ:CME) to Announce $1.89 EPS

Brokerages expect CME Group Inc. (NASDAQ:CMEGet Rating) to announce earnings of $1.89 per share for the current fiscal quarter, according to Zacks Investment Research. Six analysts have provided estimates for CME Group’s earnings. The highest EPS estimate is $1.96 and the lowest is $1.85. CME Group reported earnings of $1.64 per share in the same quarter last year, which would suggest a positive year over year growth rate of 15.2%. The firm is expected to issue its next earnings results on Monday, January 1st.

According to Zacks, analysts expect that CME Group will report full year earnings of $7.90 per share for the current financial year, with EPS estimates ranging from $7.40 to $8.35. For the next fiscal year, analysts forecast that the firm will report earnings of $8.35 per share, with EPS estimates ranging from $7.84 to $9.33. Zacks’ EPS averages are a mean average based on a survey of research firms that cover CME Group.

CME Group (NASDAQ:CMEGet Rating) last released its quarterly earnings data on Wednesday, April 27th. The financial services provider reported $2.11 earnings per share for the quarter, beating the consensus estimate of $2.00 by $0.11. The business had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.33 billion. CME Group had a return on equity of 9.29% and a net margin of 57.98%. CME Group’s revenue was up 7.4% compared to the same quarter last year. During the same period last year, the firm posted $1.79 earnings per share.

Several research firms recently weighed in on CME. Credit Suisse Group reduced their price objective on CME Group from $265.00 to $262.00 and set a “neutral” rating on the stock in a research note on Tuesday, April 5th. Bank of America raised their price objective on CME Group from $244.00 to $252.00 and gave the company an “underperform” rating in a research note on Thursday, February 10th. Rosenblatt Securities cut their price target on CME Group from $268.00 to $267.00 and set a “neutral” rating on the stock in a research note on Thursday, April 14th. StockNews.com assumed coverage on CME Group in a research note on Thursday, March 31st. They set a “hold” rating on the stock. Finally, Compass Point lifted their price target on CME Group from $235.00 to $250.00 and gave the company a “neutral” rating in a research note on Thursday, February 10th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $254.75.

NASDAQ:CME opened at $220.66 on Thursday. The stock’s 50-day simple moving average is $235.57 and its 200 day simple moving average is $230.17. The firm has a market capitalization of $79.31 billion, a PE ratio of 28.81, a price-to-earnings-growth ratio of 4.47 and a beta of 0.47. The company has a quick ratio of 1.01, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group has a twelve month low of $185.79 and a twelve month high of $256.94.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 27th. Investors of record on Friday, June 10th will be paid a $1.00 dividend. This represents a $4.00 dividend on an annualized basis and a dividend yield of 1.81%. CME Group’s dividend payout ratio is currently 52.22%.

In other CME Group news, insider Sean Tully sold 4,000 shares of CME Group stock in a transaction that occurred on Monday, March 14th. The stock was sold at an average price of $229.80, for a total value of $919,200.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Kevin Kometer sold 13,500 shares of CME Group stock in a transaction that occurred on Thursday, February 10th. The stock was sold at an average price of $244.04, for a total value of $3,294,540.00. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 32,650 shares of company stock worth $7,814,564. 0.30% of the stock is owned by insiders.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Bromfield Sneider Wealth Advisors bought a new stake in shares of CME Group during the first quarter valued at approximately $26,000. Cornerstone Advisory LLC purchased a new position in shares of CME Group during the fourth quarter valued at approximately $29,000. Quent Capital LLC purchased a new position in shares of CME Group during the fourth quarter valued at approximately $38,000. Crewe Advisors LLC purchased a new position in shares of CME Group during the first quarter valued at approximately $42,000. Finally, St. James Investment Advisors LLC purchased a new position in shares of CME Group during the fourth quarter valued at approximately $42,000. Hedge funds and other institutional investors own 86.71% of the company’s stock.

CME Group Company Profile (Get Rating)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products.

Recommended Stories

Get a free copy of the Zacks research report on CME Group (CME)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.